HMG-CoA reductase inhibitors (statins) activate expression of PPARα/PPARγ and ABCA1 in cultured gallbladder epithelial cells

Digestive Diseases and Sciences

Volumn 55, Issue 2, 2010, Pages 292-299

  Lee, Jin ^a   Hong, Eun Mi ^a   Koh, Dong Hee ^a   Choi, Min Ho ^a   Jang, Hyun Joo ^a   Kae, Sea Hyub ^a   Choi, Ho Soon ^b  

^a Hallym University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

ABCA1; Gallbladder; HMG CoA reductase inhibitor (statin); PPAR ; PPAR

Indexed keywords

ABC TRANSPORTER A1; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; PRAVASTATIN; SIMVASTATIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; ABC TRANSPORTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOG; DRUG EFFECT; GALLBLADDER EPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; EPITHELIUM CELL; GALLBLADDER; GENE EXPRESSION; GENETICS; METABOLISM;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELLS, CULTURED; DOGS; EPITHELIAL CELLS; GALLBLADDER; GENE EXPRESSION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PPAR ALPHA; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 76849108262     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0734-3     Document Type: Article

References (49)

1. HU Marschall C Einarsson 2007 Gallstone disease J Intern Med 261 529 542 10.1111/j.1365-2796.2007.01783.x 1:CAS:528:DC%2BD2sXot12lu7Y%3D 17547709 (Pubitemid 46835981)
2. MC Carey 1993 Pathogenesis of gallstones Am J Surg 165 410 419 10.1016/S0002-9610(05)80932-8 1:STN:280:DyaK3s3ktlGiug%3D%3D 8480873
3. R Daynes DC Jones 2002 Emerging roles of PPARs in inflammation and immunity Nat Rev Immunol 2 748 759 10.1038/nri912 1:CAS:528:DC%2BD38XnsVGqsbY%3D 12360213 (Pubitemid 37328715)
4. MA Simonin K Bordji S Boyault A Bianchi E Gouze P Bécuwe M Dauça P Netter B Terlain 2002 PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts Am J Physiol Cell Physiol 282 C125 C133 1:CAS:528:DC%2BD38XlsVKntA%3D%3D 11742805
5. J Lee EM Hong HW Byun MH Choi HJ Jang CS Eun SH Kae HS Choi 2008 The effect of PPARalpha and PPARgamma ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells Dig Dis Sci 53 1707 1715 10.1007/s10620-007-0029-5 1:CAS:528:DC%2BD1cXlt1Siu70%3D 17932758 (Pubitemid 351624415)
6. DS Ory 2004 Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ Res 95 660 670 10.1161/01.RES.0000143422.83209.be 1:CAS:528:DC%2BD2cXnvVekur8%3D 15459087 (Pubitemid 39331925)
7. ML Fitzgerald KJ Moore MW Freeman 2002 Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home J Mol Med 80 271 281 10.1007/s00109-001-0318-y 1:CAS:528:DC%2BD38XltlOksbo%3D 12021839 (Pubitemid 34507887)
8. G Chinetti S Lestavel V Bocher AT Remaley B Neve IP Torra E Teissier A Minnich M Jaye N Duverger HB Brewer JC Fruchart V Clavey B Staels 2001 PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 53 58 10.1038/83348 1:CAS:528:DC%2BD3MXmvFShtg%3D%3D 11135616 (Pubitemid 32095642)
9. J Lee A Shirk JF Oram SP Lee R Kuver 2002 Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway Biochem J 364 475 484 10.1042/BJ20011493 1:CAS:528:DC%2BD38XkvVamtL0%3D 12023891 (Pubitemid 34620808)
10. J Lee A Tauscher DW Seo JF Oram R Kuver 2003 Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E Am J Physiol Gastrointest Liver Physiol 285 G630 G641 1:CAS:528:DC%2BD3sXnsVGmu78%3D 12773300
11. SM Post H Duez PP Gervois B Staels F Kuipers HM Princen 2001 Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression Arterioscler Thromb Vasc Biol 21 1840 1845 10.1161/hq1101.098228 1:CAS:528:DC%2BD3MXosVKnurw%3D 11701475
12. FX Caroli-Bosc P Le Gall P Pugliese B Delabre C Caroli-Bosc JF Demarquay JP Delmont P Rampal JC Montet 2001 Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population Dig Dis Sci 46 540 544 10.1023/A:1005643014395 1:CAS:528: DC%2BD3MXjtlGkt70%3D 11318529 (Pubitemid 32299807)
13. Z Hussein JM Wentworth AJ Nankervis J Proietto PG Colman 2004 Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital Med J Aust 181 536 539 15540964
14. P Fan B Zhang S Kuroki K Saku 2004 Pitavastatin, a potent hydroxymethylglutaryl coenzyme a reductase inhibitor, increases cholesterol 7 alpha-hydroxylase gene expression in HepG2 cells Circ J 68 1061 1066 10.1253/circj.68.1061 1:CAS:528:DC%2BD2cXhtFakur7I 15502389 (Pubitemid 39540138)
15. M Jasińska J Owczarek D Orszulak-Michalak 2007 Statins: a new insight into their mechanisms of action and consequent pleiotropic effects Pharmacol Rep 59 483 499 18048949
16. R Paumelle C Blanquart O Briand O Barbier C Duhem G Woerly F Percevault JC Fruchart D Dombrowicz C Glineur B Staels 2006 Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway Circ Res 98 361 369 10.1161/01.RES.0000202706.70992.95 1:CAS:528:DC%2BD28Xht1Cmurw%3D 16397146 (Pubitemid 43755332)
17. A Planavila JC Laguna M Vázquez-Carrera 2005 Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation Biochim Biophys Acta 1687 76 83 1:CAS:528:DC%2BD2MXhtlSrs7o%3D 15708355
18. O Grip S Janciauskiene S Lindgren 2002 Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes Inflamm Res 51 58 62 10.1007/BF02684000 1:CAS:528:DC%2BD38XhvF2hur8%3D 11926313
19. J Armitage 2007 The safety of statins in clinical practice Lancet 370 1781 1790 10.1016/S0140-6736(07)60716-8 1:CAS:528:DC%2BD2sXhtlCrtLnM 17559928 (Pubitemid 350137473)
20. JL Smith PD Roach LN Wittenberg M Riottot SP Pillay PJ Nestel LK Nathanson 2000 Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones J Gastroenterol Hepatol 15 871 879 10.1046/j.1440-1746.2000.02231.x 1:CAS:528:DC%2BD3cXnt12ku7Y%3D 11022827 (Pubitemid 30744911)
21. M Porsch-Ozçürümez PD Hardt H Schnell-Kretschmer K von Bergmann C Darui J Nonhoff C Abletshauser HU Klör 2001 Effects of fluvastatin on biliary lipids in subjects with an elevated cholesterol saturation index Eur J Clin Pharmacol 56 873 879 10.1007/s002280000254 11317474 (Pubitemid 33788563)
22. BA Chapman MJ Burt RJ Chisholm RB Allan KH Yeo AG Ross 1998 Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor Dig Dis Sci 43 349 353 10.1023/A:1018862507469 1:CAS:528:DyaK1cXitlChs70%3D 9512129 (Pubitemid 28124612)
23. BC Sharma DK Agarwal SS Baijal VA Saraswat 1997 Pravastatin has no effect on bile lipid composition, nucleation time, and gallbladder motility in persons with normal levels of cholesterol J Clin Gastroenterol 25 433 436 10.1097/00004836-199709000-00007 1:STN:280:DyaK1c%2FnsVChtg%3D%3D 9412944 (Pubitemid 27528125)
24. JW Smit KJ van Erpecum W Renooij MF Stolk P Edgar H Doornewaard GP Vanberge-Henegouwen 1995 The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease Hepatology 21 1523 1529 1:STN:280:DyaK2M3os1Wgtg%3D%3D 7768495
25. I Zanotti F Poti E Favari KR Steffensen JA Gustafsson F Bernini 2006 Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP J Pharmacol Exp Ther 317 395 401 10.1124/jpet.105.093930 1:CAS:528:DC%2BD28XjsVWmurw%3D 16415093
26. Y Zhu HJ Wang LF Chen Q Fang XW Yan 2007 Study of ATP-binding cassette transporter A1 (ABCA1)-mediated cellular cholesterol efflux in diabetic golden hamsters J Int Med Res 35 508 516 1:CAS:528:DC%2BD2sXhtVers7fL 17697528
27. J Wong CM Quinn AJ Brown 2004 Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux Arterioscler Thromb Vasc Biol 24 2365 2371 10.1161/01.ATV. 0000148707.93054.7d 1:CAS:528:DC%2BD2cXhtVaisrjL 15514210 (Pubitemid 39658043)
28. H Ando S Tsuruoka H Yamamoto T Takamura S Kaneko A Fujimura 2004 Effects of pravastatin on the expression of ATP-binding cassette transporter A1 J Pharmacol Exp Ther 311 420 425 10.1124/jpet.104.068213 1:CAS:528: DC%2BD2cXosVKrtbc%3D 15210833 (Pubitemid 39287824)
29. H Sone H Shimano M Shu M Nakakuki A Takahashi M Sakai Y Sakamoto T Yokoo K Matsuzaka H Okazaki Y Nakagawa KT Iida H Suzuki H Toyoshima S Horiuchi N Yamada 2004 Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages Biochem Biophys Res Commun 316 790 794 10.1016/j.bbrc.2004.02.121 1:CAS:528:DC%2BD2cXitFKgsbo%3D 15033469 (Pubitemid 38368021)
30. D Oda SP Lee A Hayashi 1991 Long-term culture and partial characterization of dog gallbladder epithelial cells Lab Invest 64 682 693 1:STN:280:DyaK3M3jt1aitg%3D%3D 1709426
31. E Shaffer 2005 Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st Century? Curr Gastroenterol Rep 7 132 140 10.1007/s11894-005-0051-8 15802102
32. MW Russo JT Wei MT Thiny LM Gangarosa A Brown Y Ringel NJ Shaheen RS Sandler 2004 Digestive and liver diseases statistics Gastroenterology 126 1448 1453 10.1053/j.gastro.2004.01.025 15131804 (Pubitemid 38552807)
33. JE Everhart M Khare M Hill KR Maurer 1999 Prevalence and ethnic differences in gallbladder disease in the United States Gastroenterology 117 632 639 10.1016/S0016-5085(99)70456-7 1:STN:280:DyaK1MzpsV2qug%3D%3D 10464139 (Pubitemid 29409249)
34. R Aerts F Penninckz 2003 The burden of gallstone disease in Europe Aliment Pharmacol Ther 18 suppl3 49 53 10.1046/j.0953-0673.2003.01721.x 14531741
35. F Keus IA Broeders CJ van Laarhoven 2006 Gallstone disease: surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis Best Pract Res Clin Gastroenterol 20 1031 1051 10.1016/j.bpg.2006.05.008 1:STN:280:DC%2BD28noslKisA%3D%3D 17127186 (Pubitemid 44774808)
36. JW Smit KJ van Erpecum MF Stolk RA Geerdink OJ Cluysenaer DW Erkelens GP van Berge Henegouwen 1992 Successful dissolution of cholesterol gallstone during treatment with pravastatin Gastroenterology 103 1068 1070 1:STN:280: DyaK38zmtlWhtw%3D%3D 1499908
37. S Tazuma S Hatsushika N Aihara H Sagawa G Yamashita M Sasaki H Sasaki S Mizuno S Tao G Kajiyama 1992 Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs Digestion 51 179 184 10.1159/000200894 1:CAS:528:DyaK38XltVCjsLk%3D 1521718
38. KG Davis TM Wertin JP Schriver 2003 The use of simvastatin for the prevention of gallstones in the lithogenic prairie dog model Obes Surg 13 865 868 10.1381/096089203322618678 14738672 (Pubitemid 38010706)
39. MZ Abedin SC Narins EH Park PR Smith KS Kirkwood 2002 Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs Dig Dis Sci 47 2192 2210 10.1023/A:1020174908650 1:CAS:528: DC%2BD38XmvFGht7g%3D 12395892 (Pubitemid 35205294)
40. Y Ye SP Nishi S Manickavasagam Y Lin MH Huang JR Perez-Polo BF Uretsky Y Birnbaum 2007 Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12, 14-PGJ2 Prostaglandins Other Lipid Mediat 84 43 53 10.1016/j.prostaglandins.2007.04.001 1:CAS:528:DC%2BD2sXnvF2nt7c%3D 17643887 (Pubitemid 47069933)
41. M Yano T Matsumura T Senokuchi N Ishii Y Murata K Taketa H Motoshima T Taguchi K Sonoda D Kukidome Y Takuwa T Kawada M Brownlee T Nishikawa E Araki 2007 Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages Circ Res 100 1442 1451 10.1161/01.RES.0000268411.49545.9c 1:CAS:528:DC%2BD2sXltl2ntr4%3D 17463321 (Pubitemid 46834756)
42. N Roglans M Vázquez-Carrera M Alegret F Novell D Zambón E Ros JC Laguna RM Sánchez 2004 Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients Eur J Clin Pharmacol 59 855 861 10.1007/s00228-003-0704-1 1:CAS:528:DC%2BD2cXhsVOgtrY%3D 14685799 (Pubitemid 38333675)
43. K Hudson S Mojumder AJ Day 1983 The effect of bezafibrate and clofibrate on cholesterol ester metabolism in rabbit peritoneal macrophages stimulated with acetylated low density lipoproteins Exp Mol Pathol 38 77 81 10.1016/0014-4800(83)90100-4 1:CAS:528:DyaL3sXitV2rsbs%3D 6832340 (Pubitemid 13161006)
44. A Kosters RJ Frijters FG Schaap E Vink T Plösch R Ottenhoff M Jirsa IM De Cuyper F Kuipers AK Groen 2003 Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice J Hepatol 38 710 716 10.1016/S0168-8278(03)00093-X 1:CAS:528: DC%2BD3sXjvFWns7o%3D 12763362 (Pubitemid 36613335)
45. A Moschetta AL Bookout DJ Mangelsdorf 2004 Prevention of cholesterol gallstone disease by FXR agonists in a mouse model Nat Med 10 1352 1358 10.1038/nm1138 1:CAS:528:DC%2BD2cXhtVCisbfE 15558057 (Pubitemid 40022717)
46. JH Miyake SL Wang RA Davis 2000 Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase J Biol Chem 275 21805 21808 10.1074/jbc.C000275200 1:CAS:528:DC%2BD3cXltFGjt74%3D 10823815 (Pubitemid 30621747)
47. M Bertolotti C Gabbi C Anzivino N Mitro C Godio E De Fabiani M Crestani M Del Puppo M Ricchi L Carulli A Rossi P Loria N Carulli 2006 Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis Eur J Clin Invest 36 170 175 10.1111/j.1365-2362.2006.01607.x 1:CAS:528: DC%2BD28XjsFSgsLk%3D 16506961 (Pubitemid 43341267)
48. L Van Aelst C D'Souza-Schorey 1997 Rho GTPases and signaling networks Genes Dev 11 2295 2322 10.1101/gad.11.18.2295 9308960
49. CA Argmann JY Edwards CG Sawyez CH O'Neil RA Hegele JG Pickering MW Huff 2005 Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl- CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux J Biol Chem 280 22212 22221 10.1074/jbc.M502761200 1:CAS:528:DC%2BD2MXksl2htro%3D 15817453 (Pubitemid 40827878)